1. Home
  2. DLPN vs EDSA Comparison

DLPN vs EDSA Comparison

Compare DLPN & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DLPN
  • EDSA
  • Stock Information
  • Founded
  • DLPN N/A
  • EDSA 2015
  • Country
  • DLPN United States
  • EDSA Canada
  • Employees
  • DLPN N/A
  • EDSA N/A
  • Industry
  • DLPN Other Consumer Services
  • EDSA Biotechnology: Pharmaceutical Preparations
  • Sector
  • DLPN Consumer Discretionary
  • EDSA Health Care
  • Exchange
  • DLPN Nasdaq
  • EDSA Nasdaq
  • Market Cap
  • DLPN 15.8M
  • EDSA 13.8M
  • IPO Year
  • DLPN N/A
  • EDSA N/A
  • Fundamental
  • Price
  • DLPN $0.68
  • EDSA $4.23
  • Analyst Decision
  • DLPN
  • EDSA Strong Buy
  • Analyst Count
  • DLPN 0
  • EDSA 2
  • Target Price
  • DLPN N/A
  • EDSA $39.00
  • AVG Volume (30 Days)
  • DLPN 36.3K
  • EDSA 13.5K
  • Earning Date
  • DLPN 11-12-2024
  • EDSA 08-09-2024
  • Dividend Yield
  • DLPN N/A
  • EDSA N/A
  • EPS Growth
  • DLPN N/A
  • EDSA N/A
  • EPS
  • DLPN N/A
  • EDSA N/A
  • Revenue
  • DLPN $48,891,700.00
  • EDSA N/A
  • Revenue This Year
  • DLPN $19.92
  • EDSA N/A
  • Revenue Next Year
  • DLPN $8.88
  • EDSA N/A
  • P/E Ratio
  • DLPN N/A
  • EDSA N/A
  • Revenue Growth
  • DLPN 16.54
  • EDSA N/A
  • 52 Week Low
  • DLPN $0.51
  • EDSA $2.50
  • 52 Week High
  • DLPN $2.00
  • EDSA $6.46
  • Technical
  • Relative Strength Index (RSI)
  • DLPN 39.45
  • EDSA 38.31
  • Support Level
  • DLPN $0.60
  • EDSA $4.00
  • Resistance Level
  • DLPN $0.72
  • EDSA $4.44
  • Average True Range (ATR)
  • DLPN 0.07
  • EDSA 0.24
  • MACD
  • DLPN 0.00
  • EDSA -0.03
  • Stochastic Oscillator
  • DLPN 35.71
  • EDSA 4.77

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.

Share on Social Networks: